An updated analysis of the eNRGy trial showed that zenocutuzumab may provide meaningful benefit beyond initial disease progression.
Zhaohui Liao Arter, MD
Advertisement
Articles by Zhaohui Liao Arter, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel Agent Earns FDA Breakthrough Therapy Designation for HPV+ Oropharyngeal Cancer
2
Debating Camizestrant, ctDNA Monitoring, and SERENA-6 in HR+ Breast Cancer
3
Signatera ctDNA Test Shows Superior MRD Assessment in Lymphoma
4
Saturated Fat Intake Linked to Greater Mortality in Nonmetastatic Prostate Cancer
5